Indian women increasingly turn to GLP-1 drugs for PCOS treatment beyond diabetes and obesity. GLP-1 medications, primarily prescribed for type-2 diabetes and weight management, are showing significant metabolic benefits for polycystic ovary syndrome patients. These drugs reduce insulin resistance, facilitate weight loss, and ease symptoms including irregular periods and acne. Doctors report improved fertility outcomes in some cases. The trend is accelerating across India with cheaper generic options entering the market. While GLP-1s remain officially indicated for diabetes and obesity, their off-label use for PCOS reflects a broader recognition of insulin resistance as a core driver of the condition.
Post from MarketNews_en
Log in to interact with content.